|
|
Article: Reports from University of Munich describe recent advances in altitude sickness.(Report)
- Article from:
- Biotech Week
- Article date:
- March 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research from Munich, Germany, "Acute mountain sickness (AMS) affects some new arrivals above all altitude of 2500 m. Hypobaric hypoxia is known to produce diuresis and has natriuretic effects due to the release of natriuretic peptides. We tested the hypothesis that increases in brain natriuretic peptide (BNP) at altitude, correlates with increased urination and natriuresis as well as symptomatic AMS."
"Subjects were 14 mountaineers who undertook a Himalayan expedition that began at 100 m and passed through 3440 m en route to a final altitude of 5050 m. We, measured the severity of AMS (Lake Louise Score), BNP values, nocturnal urine volume, ...